Published on 09/07/2021
12-15 November, 2021 Hybrid edition
ENYO Pharma will attend the 2021 edition of AASLD / The Liver meeting.
ENYO Pharma Announces Completion and Topline Data from Phase 2 ALPESTRIA-1 Clinical Study in Alport Syndrome Demonstrating Vonafexor Reverses Kidney Function Decline and has Sustai...
Latest Press Release 